The pharmaceutical giant Roche has said the low levels of Covid-19 prevalence in the UK have made it hard to find enough participants to finish their trial of an ingestible treatment for the disease. Speaking on Wednesday, Bill Anderson, the head of Roche’s pharmaceutical division, told Reuters that it was taking longer than expected to finish their trial. The company’s chairman Christoph Franz had previously indicated results might be available before the end of March. “There’s just simply not enough patients to enrol… with the speed we were hoping for,” Anderson stated, noting that the UK’s strict lockdown and fast vaccination progra
Hence then, the article about swiss drugmaker roche searching for new site to trial covid 19 pill as virus prevalence in uk falls was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Swiss drugmaker Roche searching for new site to trial Covid-19 pill as virus prevalence in UK falls )